Georges Saab David G Munoz Dalia L Rotstein
10.3389/fneur.2022.863151
Front Neurol
2022 May 13;13:863151.
neuromyelitis optica spectrum disorder (nmosd) aquaporin-4 (aqp4) cognitive impairment corpus callosum eculizumab
CC BY
https://pubmed.ncbi.nlm.nih.gov/35645973/
Case Reports
PMC9136286
35645973
Chronic Cognitive Impairment in AQP4+ NMOSD With Improvement in Cognition on Eculizumab: A Report of Two Cases
2022